coronary artery disease Clinical Trials and Research
Also known as: atherosclerotic heart disease, ischemic heart disease, heart artery disease, cad, coronary heart disease, hardening of the arteries, blocked arteries · ICD-10: I25.1-
Coronary artery disease (CAD) occurs when the heart's major blood vessels narrow, reducing blood flow. Clinical trial research focuses on developing new treatments, prevention strategies, and better diagnostic tools for CAD. Find a Trial helps patients search for active studies.
Search coronary artery disease trials →
Common questions about coronary artery disease clinical trials
Who can participate in clinical trials for coronary artery disease?
Eligibility criteria vary by study, often including factors like age, CAD severity, and overall health status. Researchers use these criteria to ensure patient safety and gather relevant data, as detailed on ClinicalTrials.gov.
What are the different phases of clinical trials for CAD?
Clinical trials progress through phases (1-4). Early phases test safety and dosage, while later phases evaluate effectiveness and compare new treatments to existing ones. This structured approach helps ensure new therapies are thoroughly vetted.
Do clinical trials for coronary artery disease cost money to participate?
Generally, study-related medical care and interventions are provided at no cost to participants. However, some trials may not cover travel or other personal expenses. Specific details are always outlined in the informed consent form.
What new treatments are being studied for coronary artery disease?
Current research, as shown on ClinicalTrials.gov and NIH RePORTER, explores novel drug therapies, advanced surgical techniques, and gene-based interventions. Scientists are also investigating stem cell therapies to repair damaged heart tissue.
What types of interventions are commonly tested in CAD clinical trials?
Trials frequently investigate new medications to lower cholesterol or blood pressure, improved angioplasty and stenting procedures, and advanced bypass surgery techniques. Lifestyle interventions, like diet and exercise programs, are also studied.
Are there specific biomarkers important in CAD clinical trials?
Researchers often study biomarkers like high-sensitivity C-reactive protein (hs-CRP), troponin, and various lipid profiles. These help assess disease progression, treatment response, and risk stratification, as documented on ClinicalTrials.gov.
What might prevent someone from joining a CAD clinical trial?
Common exclusion criteria include severe co-existing medical conditions, recent heart attack or stroke, or certain medication use. These are in place to protect participants and ensure study results are clear and interpretable.
Are there clinical trials focused on preventing coronary artery disease?
Yes, many trials investigate strategies to prevent CAD development or progression. These include studies on diet, exercise, new cholesterol-lowering drugs, and interventions for risk factors like diabetes and high blood pressure, often funded by NIH RePORTER.
How to find a coronary artery disease trial that fits you
- Describe your coronary artery disease situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all coronary artery disease trials →